
Therapies Which Received FDA Approval in July: What Patients Should Know
In June of 2025, the U.S. Food and Drug Administration (FDA) approved multiple cancer treatments and combination therapies across a range of indications, including lung and prostate cancers, as well as chronic lymphocytic leukemia. Here is a list of cancer …